Waz, D. et al. 2025. Biosimilars in Focus: Evaluating Their Role Compared to Adalimumab in Clinical Practice. Quality in Sport. 38, (Jan. 2025), 57232. DOI:https://doi.org/10.12775/QS.2025.38.57232.